Ignite Creation Date:
2025-12-25 @ 3:08 AM
Ignite Modification Date:
2026-01-01 @ 5:55 AM
Study NCT ID:
NCT01520805
Status:
WITHDRAWN
Last Update Posted:
2016-12-29
First Post:
2012-01-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Effectiveness Study of CPI-613 to Treat Refractory or Relapsed Leukemia and Myelodysplastic Syndrome
Sponsor:
Cornerstone Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-01
Start Date Type:
None
Primary Completion Date:
2018-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2018-12
Completion Date Type:
ESTIMATED
First Submit Date:
2012-01-20
First Submit QC Date:
None
Study First Post Date:
2012-01-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-12-27
Last Update Post Date:
2016-12-29
Last Update Post Date Type:
ESTIMATED